Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07383558

Effect of Additional Sural Nerve PRF in Chronic Heel Pain

Does Targeting the Sural Nerve in Addition to the Posterior Tibial Nerve Increase the Effectiveness of Pulsed Radiofrequency Treatment in Chronic Plantar Heel Pain?

Status
Recruiting
Phase
Study type
Observational
Enrollment
48 (estimated)
Sponsor
Diskapi Teaching and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This observational study aims to compare the effectiveness of pulsed radiofrequency (PRF) treatment applied to the posterior tibial nerve alone versus PRF applied to both the posterior tibial and sural nerves in patients with chronic plantar heel pain. Outcomes will be assessed using the Visual Analog Scale (VAS) and the American Orthopaedic Foot and Ankle Society (AOFAS) hindfoot score at baseline, 1 month, and 3 months after treatment.

Detailed description

Chronic plantar heel pain is a common condition frequently managed with interventional pain procedures. In routine clinical practice, pulsed radiofrequency (PRF) is commonly applied to the posterior tibial nerve under ultrasound guidance. In selected patients, PRF is additionally applied to the sural nerve based on clinical judgment. This observational study includes patients who have already undergone PRF treatment as part of standard care in the Algology Clinic. Patients will not be randomized, and no modification to treatment plans will be made for study purposes. Patients will be divided into two groups: those who received PRF to the posterior tibial nerve alone, and those who received PRF to both the posterior tibial and sural nerves. Pain intensity and functional outcomes will be retrospectively evaluated and compared between groups.

Conditions

Interventions

TypeNameDescription
PROCEDUREPulsed radiofrequencyUltrasound-guided pulsed radiofrequency applied to the posterior tibial nerve, with or without additional application to the sural nerve.

Timeline

Start date
2025-06-01
Primary completion
2026-05-01
Completion
2026-09-01
First posted
2026-02-03
Last updated
2026-02-25

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07383558. Inclusion in this directory is not an endorsement.